Andrada Mining acquisition elevates the miner to emerging mid-tier status. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAstrazeneca Share News (AZN)

Share Price Information for Astrazeneca (AZN)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 12,328.00
Bid: 12,346.00
Ask: 12,348.00
Change: -228.00 (-1.82%)
Spread: 2.00 (0.016%)
Open: 12,512.00
High: 12,554.00
Low: 12,328.00
Prev. Close: 12,556.00
AZN Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

UPDATE 3-UK begins rollout of Moderna COVID vaccine as daily rollout slows

Wed, 07th Apr 2021 06:56

* UK begins using Moderna's shot

* UK daily rollout slows to lowest level this year

* PM Johnson: Get a shot
(Adds context)

By Guy Faulconbridge and Kate Holton

LONDON, April 7 (Reuters) - Britain begins using Moderna's
COVID-19 vaccine on Wednesday in Wales just as its rollout of
other shots has fallen to its lowest level this year due to a
supply crunch caused by manufacturing problems at AstraZeneca.

Britain has surged ahead of the rest of Europe in the race
to vaccinate its population, with almost half of its citizens
receiving a first dose, but supply issues from its main
Oxford-AstraZeneca shot have slowed progress in recent
days.

Britain distributed almost 96,000 shots on Sunday and just
over 105,000 on Monday, the lowest figures since the government
started publishing daily numbers in January.

British ministers had warned the rollout would slow in April
due to AstraZeneca's manufacturing issues, including at a site
in India.

"The Moderna vaccine rollout begins today, starting with
Carmarthen in Wales," Prime Minister Boris Johnson said. "We
have ordered 17 million doses that will be going into arms
across the UK in the coming weeks.

"Please get your jab as soon as you are contacted."

Moderna, whose shots are already being used in the United
States and other parts of Europe, will become the third vaccine
to be used in Britain after the AstraZeneca shot and one from
Pfizer-BioNTech .

It uses the same mRNA technology as Pfizer's shot but can be
stored at normal fridge temperatures unlike its rival U.S.
vaccine, which must be stored and shipped at ultra-cool
temperatures.

Junior business minister Paul Scully told Sky News the
Moderna shot would reach the rest of the United Kingdom in the
coming days.

"You've heard the vaccine minister Nadhim Zahawi talking
about the third week of April. We're already just about to start
the second week of April so that's not too long to wait."

The United Kingdom has vaccinated 31.6 million people with a
first dose of a COVID-19 vaccine - and administered 5.5 million
second doses. In recent weeks, cases, hospitalisations and
deaths have all fallen.

Israel is the world leader in vaccinating its population
against COVID-19, followed by the United Arab Emirates, Chile,
the United Kingdom, the United States, Bahrain, Serbia and
Hungary, according to Our World in Data.
(Reporting by Guy Faulconbridge and Costas Pitas; Editing by
William Schomberg and Mark Potter)

More News
11 Apr 2024 17:13

FTSE 100 edges lower as financials drag

Lok'nStore surges to all-time high after buyout by Shurgard

*

Read more
11 Apr 2024 17:07

Banks weigh down Europe's STOXX 600 after ECB signals rate cuts

Outlook hike sends Ambu shares up

*

Read more
11 Apr 2024 15:56

London close: Stocks finish lower as ECB stands pat

(Sharecast News) - London's stock markets finished in negative territory on Thursday, as investors reacted to the European Central Bank's latest policy announcement and a producer price index release in the United States.

Read more
11 Apr 2024 11:50

LONDON MARKET MIDDAY: Europe takes hit on nerves ahead of ECB decision

(Alliance News) - European equities sunk lower at midday on Thursday, with sentiment hurt by hotter-than-expected inflation from the US crushing hopes of interest rate cuts.

Read more
11 Apr 2024 08:56

TOP NEWS: Astra plans 7% dividend hike for 2024 after no rise in 2023

(Alliance News) - AstraZeneca PLC said it intends to raise its annualised dividend for 2024, citing confidence in its business performance and cash generation.

Read more
11 Apr 2024 08:54

LONDON MARKET OPEN: European markets mixed ahead of ECB decision

(Alliance News) - European equities lacked direction early Thursday morning, ahead of an interest rate decision from the European Central Bank this afternoon.

Read more
11 Apr 2024 07:49

LONDON BRIEFING: Astra promises dividend hike; Darktrace ups guidance

(Alliance News) - Stocks in London are called to open slightly higher on Thursday, as investors eye the latest interest rate decision from the European Central Bank, a day after a hotter-than-expected US inflation reading.

Read more
11 Apr 2024 07:20

AstraZeneca to hike 2024 dividend by 7%

(Sharecast News) - Biopharma giant AstraZeneca has announced that it will increase its annual dividend by 7%, which the board said demonstrates its confidence in the company's performance and cash generation.

Read more
8 Apr 2024 08:36

TOP NEWS: AstraZeneca hails neurological data for Ultomiris, Soliris

(Alliance News) - AstraZeneca PLC on Monday said long-term data in generalised myasthenia gravis will underscore the "vital role" of its Ultomiris and Soliris antibodies in the treatment landscape.

Read more
8 Apr 2024 07:43

LONDON BRIEFING: Astra hails neurology data; CVS flags cyberattack

(Alliance News) - London's FTSE 100 is called to open a touch higher on Monday, ahead of an interest rate decision in the eurozone and a US inflation reading later in the week.

Read more
8 Apr 2024 07:02

AstraZeneca's Enhurtu cancer gets US green light for adult patients

(Sharecast News) - AstraZeneca and Daiichi Sankyo's Enhertu cancer drug has been approved in the US for adult patients with unresectable or metastatic solid tumours who have received prior systemic treatment and have no satisfactory alternative options.

Read more
8 Apr 2024 06:53

TOP NEWS: AstraZeneca's, Daiichi's Enhertu receives US FDA approval

(Alliance News) - AstraZeneca PLC and Daiichi Sankyo Co Ltd on Saturday announced that the US Food & Drug Administration has approved their cancer drug conjugate for patients with metastatic HER2-positive solid tumours.

Read more
5 Apr 2024 09:42

AstraZeneca makes "breakthrough" in treating small cell lung cancer

(Alliance News) - AstraZeneca PLC on Friday reported positive results relating to its Imfinzi cancer treatment in phase III trials.

Read more
5 Apr 2024 07:50

LONDON BRIEFING: Shell to book USD600 million first-quarter write-off

(Alliance News) - London's FTSE 100 is called to open lower on Friday, with hawkish remarks from Federal Reserve policymakers and fears of ratcheting Middle East tensions giving investors little to cheer about ahead of the latest US jobs data.

Read more
5 Apr 2024 07:23

AstraZeneca announces positive lung cancer treatment trial results

(Sharecast News) - AstraZeneca announced positive high-level results from a phase three trial demonstrating significant advancements in the treatment of limited-stage small cell lung cancer (LS-SCLC) on Friday.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.